cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.3535/7jh-7x8-qd4
title: Sebastiania glandulosa var. pohlii (Müll. Arg.) Pax

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/46g-1yt-vr2
title: Lyperanthus suaveolens R. Br.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/8lr-dkm-9q5
title: Securinega congesta (Benth. ex Müll. Arg.) Müll. Arg.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/69q-kh6-kfw
title: Sebastiania ditassoides (Didr.) Müll. Arg.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/lyp-3sj-p28
title: Symplocos nitens var. bahiensis (A. DC.) Brand

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/rlh-cqv-jd7
title: Solanum paniculatum L.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/17z-4rj-rbs
title: Pera glabrata (Schott) Baill.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/lcd-tlg-804
title: Phyllanthus klotzschianus var. robustus Müll. Arg.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/p6s-zsz-72q
title: Pachystroma ilicifolium var. longifolium (Nees) Müll. Arg.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.13140/rg.2.2.27604.50561
title: The Complete LabVIEW code of the SPM controller
DOI: 10.3535/b7h-h1f-l2s
title: Sebastiania hispida var. intercedens (Müll. Arg.) Pax

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/e0e-2k3-dnw
title: Manihot tripartita (Spreng.) Müll. Arg.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/zed-zzn-gz2
title: Casearia commersoniana Cambess.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/50h-rls-a27
title: Romanoa tamnoides (A. Juss.) Radcl.-Sm.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/jkx-84p-lwt
title: Phyllanthus niruri var. genuinus

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/19g-126-36x
title: Styrax maninul B. Walln.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/35v-ks3-aml
title: Symplocos lanceolata A. DC.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/qaj-m4f-fkz
title: Phyllanthus subemarginatus Müll. Arg.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/444-8q0-yby
title: Phyllanthus arenicola Casar.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/88p-8rw-t19
title: Phyllanthus poeppigianus (Müll. Arg.) Müll. Arg.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/tt7-h8g-520
title: Casearia decandra Jacq.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.3535/6dk-1dz-l95
title: Cruciata taurica subsp. taurica (Pall. ex Willd.) Ehrend.

description: Digital Specimen for the physical specimen hosted at Natural History Museum Vienna.
DOI: 10.6084/m9.figshare.28415470
title: Assessing the risk of acute kidney injury associated with a four-drug regimen for heart failure: a ten-year real-world pharmacovigilance analysis based on FAERS events

description: The four-drug regimen for heart failure with reduced ejection fraction (HFrEF) significantly reduces the risks of hospitalization and mortality. To identify key adverse drug events (ADEs) warranting attention with this regimen, we conducted a real-world pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS) events. We collected ADE reports of the four-drug regimen from FAERS that matched this regimen over a 10-year period. Disproportionality analysis and subgroup analysis were performed using four algorithms. Time-to-onset (TTO) analysis was used to assess the temporal risk patterns of ADE occurrence. Lastly, logistic regression was applied to investigate the relationship-value between patient characteristics and ADEs. A total of 1,237 cases with 6,580 ADE reports were collected. Disproportionality analysis identified the most frequent ADEs as hypotension, acute kidney injury (AKI), and hyperkalemia. TTO analysis revealed a median TTO of 39 days for all important medical events, and the median TTO for AKI was 28 days, both fitting an early failure curve. In the comprehensive management of HFrEF with the four-drug regimen, in addition to routine monitoring of ADEs such as hypotension and hyperalemia, early-onset AKI should be a particular focus. Heart failure with reduced ejection fraction (HFrEF) is a condition where the heart doesn’t pump blood as well as it should. There is a recommended treatment plan that includes four specific drugs, which can help reduce the risk of hospitalization and death. However, taking multiple medications can also increase the risk of side effects, known as adverse drug events (ADEs). In this study, we analyzed reports of side effects from people taking this four-drug regimen using data from the FDA Adverse Event Reporting System (FAERS) over the past 10 years (2014–2024). We used different methods to identify common and serious side effects and looked at how quickly these side effects tend to appear after starting treatment. We also examined the role of patient characteristics, like age and body weight, in the occurrence of these side effects. We found that the most frequent side effects were low blood pressure, worsening kidney function (including acute kidney injury), and high potassium levels. On average, serious side effects occurred within 39 days of starting treatment, with kidney problems appearing even sooner (around 28 days). Older patients and males were more likely to experience kidney issues. Based on our findings, we recommend close monitoring of these side effects, especially early in treatment, and adjusting medications as needed to reduce risks. Early changes in drug doses and regular follow-up can help ensure that the treatment is both safe and effective for patients.
DOI: 10.6084/m9.figshare.28415470.v1
title: Assessing the risk of acute kidney injury associated with a four-drug regimen for heart failure: a ten-year real-world pharmacovigilance analysis based on FAERS events

description: The four-drug regimen for heart failure with reduced ejection fraction (HFrEF) significantly reduces the risks of hospitalization and mortality. To identify key adverse drug events (ADEs) warranting attention with this regimen, we conducted a real-world pharmacovigilance analysis based on the FDA Adverse Event Reporting System (FAERS) events. We collected ADE reports of the four-drug regimen from FAERS that matched this regimen over a 10-year period. Disproportionality analysis and subgroup analysis were performed using four algorithms. Time-to-onset (TTO) analysis was used to assess the temporal risk patterns of ADE occurrence. Lastly, logistic regression was applied to investigate the relationship-value between patient characteristics and ADEs. A total of 1,237 cases with 6,580 ADE reports were collected. Disproportionality analysis identified the most frequent ADEs as hypotension, acute kidney injury (AKI), and hyperkalemia. TTO analysis revealed a median TTO of 39 days for all important medical events, and the median TTO for AKI was 28 days, both fitting an early failure curve. In the comprehensive management of HFrEF with the four-drug regimen, in addition to routine monitoring of ADEs such as hypotension and hyperalemia, early-onset AKI should be a particular focus. Heart failure with reduced ejection fraction (HFrEF) is a condition where the heart doesn’t pump blood as well as it should. There is a recommended treatment plan that includes four specific drugs, which can help reduce the risk of hospitalization and death. However, taking multiple medications can also increase the risk of side effects, known as adverse drug events (ADEs). In this study, we analyzed reports of side effects from people taking this four-drug regimen using data from the FDA Adverse Event Reporting System (FAERS) over the past 10 years (2014–2024). We used different methods to identify common and serious side effects and looked at how quickly these side effects tend to appear after starting treatment. We also examined the role of patient characteristics, like age and body weight, in the occurrence of these side effects. We found that the most frequent side effects were low blood pressure, worsening kidney function (including acute kidney injury), and high potassium levels. On average, serious side effects occurred within 39 days of starting treatment, with kidney problems appearing even sooner (around 28 days). Older patients and males were more likely to experience kidney issues. Based on our findings, we recommend close monitoring of these side effects, especially early in treatment, and adjusting medications as needed to reduce risks. Early changes in drug doses and regular follow-up can help ensure that the treatment is both safe and effective for patients.
DOI: 10.6084/m9.figshare.28450537.v1
title: Hospital-wide interventions for reducing or preventing in-hospital prescribing errors: a scoping review

description: Prescribing errors (PEs) in hospital care lead to patient harm, prolonged hospital stays, readmissions, and mortality. Despite interventions that successfully target ‘high risk’ populations in trials, PE rates remain largely unchanged in real-world settings. Existing studies often focus narrowly on specific populations, overlooking the wider complexities of hospital-wide prescribing. This scoping review evaluates interventions for adult inpatients to identify knowledge gaps in how to reduce in-hospital PEs. A systematic search of PubMed, EMBASE.com, and the Cochrane Library (inception to 13 December 2024) was conducted following PRISMA-ScR guidelines. Studies prospectively evaluating interventions reducing in-hospital PEs were eligible for inclusion; those focusing on specific drugs, wards or populations or lacking original data were excluded. Fourteen studies met the inclusion criteria. Technological interventions, such as computerized order entry systems, accounted for 35.7% of the studies. Half addressed prescriber-related factors, such as inadequate drug knowledge and prescribing skills, while organizational factors were underexplored. Current interventions fail to address the underlying complexities, leaving critical gaps to decrease in-hospital PEs. To achieve sustainable PE reductions and improve patient safety, a multidisciplinary approach, standardized reporting, organizational reform, and a Safety-II perspective are essential.
DOI: 10.6084/m9.figshare.25256335
title: Speech and communication classification of children with cerebral palsy: Novice rater agreement and clinical utility

description: To examine novice inter-rater agreement and clinical utility perspectives for speech and communication classification of children with cerebral palsy (CP). Twenty-one clinicians (speech-language pathologists [SLPs] <i>n</i> = 11; physiotherapists [PTs] <i>n</i> = 5; occupational therapists [OTs] <i>n</i> = 5) novice to the Viking Speech Scale (VSS), Functional Communication Classification System (FCCS), and Communication Function Classification System (CFCS) rated eight unfamiliar children with CP (8–16 years) following classification orientation. Inter-rater agreement was examined between (a) novices, (b) novice SLPs vs. PTs and OTs, and (c) novice vs. expert (kappa statistics). Utility perceptions were scored regarding classification terminology, ease of use, assistive decision-making resources, and construct validity and were analysed using Kruskal–Wallis <i>H</i>-tests. Rating agreement between novices was substantial (VSS, <i>k</i> = 0.72, 95% CI [0.53–0.92]) to moderate (FCCS, <i>k</i> = 0.44, 95% CI [0.23–0.65]; CFCS, <i>k</i> = 0.45, 95% CI [0.18–0.71]), and almost perfect between novice and expert ratings (VSS, <i>k<sub>w</sub></i> = 0.89, 95% CI [0.86–0.92]; FCCS, <i>k<sub>w</sub></i> = 0.89, 95% CI [0.86–0.92]; CFCS, <i>k<sub>w</sub></i> = 0.86, 95% CI [0.82–0.91]). Statistically significant differences, presented highest to lowest, were found for clinical utility: terminology (VSS, FCCS, CFCS; <i>p</i> = 0.02), assistive decision-making resources (FCCS, VSS, CFCS; <i>p</i> = 0.009), and construct validity (FCCS, CFCS, VSS; <i>p</i> &lt; 0.001). Novice raters achieved substantial agreement for speech classification, supporting utilisation in clinical, research, and CP register activities. Orientation to communication classification constructs, content, and instructions is recommended for novice raters.
DOI: 10.6084/m9.figshare.25256335.v1
title: Speech and communication classification of children with cerebral palsy: Novice rater agreement and clinical utility

description: To examine novice inter-rater agreement and clinical utility perspectives for speech and communication classification of children with cerebral palsy (CP). Twenty-one clinicians (speech-language pathologists [SLPs] <i>n</i> = 11; physiotherapists [PTs] <i>n</i> = 5; occupational therapists [OTs] <i>n</i> = 5) novice to the Viking Speech Scale (VSS), Functional Communication Classification System (FCCS), and Communication Function Classification System (CFCS) rated eight unfamiliar children with CP (8–16 years) following classification orientation. Inter-rater agreement was examined between (a) novices, (b) novice SLPs vs. PTs and OTs, and (c) novice vs. expert (kappa statistics). Utility perceptions were scored regarding classification terminology, ease of use, assistive decision-making resources, and construct validity and were analysed using Kruskal–Wallis <i>H</i>-tests. Rating agreement between novices was substantial (VSS, <i>k</i> = 0.72, 95% CI [0.53–0.92]) to moderate (FCCS, <i>k</i> = 0.44, 95% CI [0.23–0.65]; CFCS, <i>k</i> = 0.45, 95% CI [0.18–0.71]), and almost perfect between novice and expert ratings (VSS, <i>k<sub>w</sub></i> = 0.89, 95% CI [0.86–0.92]; FCCS, <i>k<sub>w</sub></i> = 0.89, 95% CI [0.86–0.92]; CFCS, <i>k<sub>w</sub></i> = 0.86, 95% CI [0.82–0.91]). Statistically significant differences, presented highest to lowest, were found for clinical utility: terminology (VSS, FCCS, CFCS; <i>p</i> = 0.02), assistive decision-making resources (FCCS, VSS, CFCS; <i>p</i> = 0.009), and construct validity (FCCS, CFCS, VSS; <i>p</i> &lt; 0.001). Novice raters achieved substantial agreement for speech classification, supporting utilisation in clinical, research, and CP register activities. Orientation to communication classification constructs, content, and instructions is recommended for novice raters.
DOI: 10.6084/m9.figshare.28450537
title: Hospital-wide interventions for reducing or preventing in-hospital prescribing errors: a scoping review

description: Prescribing errors (PEs) in hospital care lead to patient harm, prolonged hospital stays, readmissions, and mortality. Despite interventions that successfully target ‘high risk’ populations in trials, PE rates remain largely unchanged in real-world settings. Existing studies often focus narrowly on specific populations, overlooking the wider complexities of hospital-wide prescribing. This scoping review evaluates interventions for adult inpatients to identify knowledge gaps in how to reduce in-hospital PEs. A systematic search of PubMed, EMBASE.com, and the Cochrane Library (inception to 13 December 2024) was conducted following PRISMA-ScR guidelines. Studies prospectively evaluating interventions reducing in-hospital PEs were eligible for inclusion; those focusing on specific drugs, wards or populations or lacking original data were excluded. Fourteen studies met the inclusion criteria. Technological interventions, such as computerized order entry systems, accounted for 35.7% of the studies. Half addressed prescriber-related factors, such as inadequate drug knowledge and prescribing skills, while organizational factors were underexplored. Current interventions fail to address the underlying complexities, leaving critical gaps to decrease in-hospital PEs. To achieve sustainable PE reductions and improve patient safety, a multidisciplinary approach, standardized reporting, organizational reform, and a Safety-II perspective are essential.
DOI: 10.6084/m9.figshare.26510322
title: Neurodevelopmental outcomes in children living near hazardous waste sites: a systematic review

description: Mismanagement of hazardous waste (HW) causes severe threats to ecosystems and human health. We conducted a systematic literature review and evaluated the evidence regarding the association between residential exposure to HW and childhood neurobehavioral effects. We consulted international agencies websites and conducted a search on MEDLINE and EMBASE databases by applying a “Population-Exposure-Comparator-Outcome” question. The evidence evaluation, based on the quality of the studies and their concordance, was graded in sufficient/limited/inadequate. Documents from international agencies were not found. Of the seventy-five studies screened, nine met the eligibility criteria. Studies agree on the association between residential exposure to HW sites and negative neurodevelopmental effects. The evidence of the association was attributed limited to cognitive and behavioral outcomes, and inadequate to Autism Spectrum Disorder. The evidence was evaluated sufficient for HW sites releasing lead and cognitive disorders. Residential exposure to unsafe HW sites may contribute to childhood neurobehavioral alterations. It is urgent to implement environmental remediation of contaminated sites and counteracting illegal and unsafe HW management practices.
DOI: 10.6084/m9.figshare.26510322.v1
title: Neurodevelopmental outcomes in children living near hazardous waste sites: a systematic review

description: Mismanagement of hazardous waste (HW) causes severe threats to ecosystems and human health. We conducted a systematic literature review and evaluated the evidence regarding the association between residential exposure to HW and childhood neurobehavioral effects. We consulted international agencies websites and conducted a search on MEDLINE and EMBASE databases by applying a “Population-Exposure-Comparator-Outcome” question. The evidence evaluation, based on the quality of the studies and their concordance, was graded in sufficient/limited/inadequate. Documents from international agencies were not found. Of the seventy-five studies screened, nine met the eligibility criteria. Studies agree on the association between residential exposure to HW sites and negative neurodevelopmental effects. The evidence of the association was attributed limited to cognitive and behavioral outcomes, and inadequate to Autism Spectrum Disorder. The evidence was evaluated sufficient for HW sites releasing lead and cognitive disorders. Residential exposure to unsafe HW sites may contribute to childhood neurobehavioral alterations. It is urgent to implement environmental remediation of contaminated sites and counteracting illegal and unsafe HW management practices.
DOI: 10.15468/dl.qs6wk7
title: Occurrence Download

description: A dataset containing 444 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Hydnellum scrobiculatum (Fr.) P.Karst.",
 "Geometry POLYGON((-8.00174339329464 54.1998526673513, 0.202120938926891 54.1998526673513, 0.202120938926891 61.2628565887411, -8.00174339329464 61.2628565887411, -8.00174339329464 54.1998526673513))",
 "CoordinateUncertaintyInMeters is 0,101",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 444 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012328-250426092105405/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.tgz3pj
title: Occurrence Download

description: A dataset containing 1427 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Continent is Asia",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "OccurrenceStatus is Present",
 "TaxonKey is Ginkgoaceae",
 "Year 1900-2025"
 ]
}

 The dataset includes 1427 records from 89 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012329-250426092105405/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.7910/dvn/ccvqx2
title: Replication Data for: Impact of the Sustainable Entrepreneurship Ecosystem on Sustainable Entrepreneurial Intentions: What Are the Primary Schools of Thought and Future Research Agenda?

description: This is the data set for the paper "Impact of the Sustainable Entrepreneurship Ecosystem on Sustainable Entrepreneurial Intentions: What Are the Primary Schools of Thought and Future Research Agenda?"
DOI: 10.15468/dl.f6wvmw
title: Occurrence Download

description: A dataset containing 12646 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Tapirus terrestris (Linnaeus, 1758)",
 "HasCoordinate is true"
 ]
}

 The dataset includes 12646 records from 123 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012331-250426092105405/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ymc43p
title: Occurrence Download

description: A dataset containing 159839 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is Aphanes L."
 ]
}

 The dataset includes 159839 records from 1334 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012320-250426092105405/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.6pkmpn
title: Occurrence Download

description: A dataset containing 9196 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Galium verum L.",
 "Geometry POLYGON((-8.00174339329464 54.1998526673513, 0.202120938926891 54.1998526673513, 0.202120938926891 61.2628565887411, -8.00174339329464 61.2628565887411, -8.00174339329464 54.1998526673513))",
 "CoordinateUncertaintyInMeters is 0,101",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 9196 records from 48 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0012332-250426092105405/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.3535/nlz-qxx-s7y
title: Capricornis sumatraensis (Bechstein, 1799)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/vtb-acx-gl9
title: Rhinoceros Linnaeus, 1758

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/8f9-fnl-8gx
title: Orthiopteris Copel.

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.